Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD

NASDAQHealthcareMedical - Care Facilities

Previous close

$8.85

+$0.28 · +3.27%

Aug 21, 4:00 PM ET

VMD company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

68

Undervalued

Momentum

69

Gaining

Sentiment

56

Mixed

Risk resilience

73

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Casey Hoyt
Listed since
Aug 9, 2019
Employees
1,438

Market position

Day range

Current $8.85

52-week range

Current $8.85

Open
$8.59
Previous close
$8.57
Volume
1.07M
3.25× average
Average volume
330.37K
Average daily volume
Market cap
337.08M USD
Beta
1.12
Market reference 1
50-day average
$10.9395
-19.10% below average
200-day average
$9.0083
-1.76% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
291.44M USD
P/E (TTM)
23.46×
P/B (TTM)
2.35×
P/S (TTM)
1.12×
EV / EBITDA
5.65×
Earnings yield
5.17%
Free cash flow yield
4.13%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
57.21%
Operating margin
8.14%
Net margin
4.81%
Return on equity
10.55%
Return on assets
6.95%
Return on invested capital
8.30%

Financial health

Debt / equity
0.08×
Current ratio
1.18×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends69%45%22%-1%Gross margin, FY2021: 62.71%Gross margin, FY2022: 60.99%Gross margin, FY2023: 61.63%Gross margin, FY2024: 59.40%Gross margin, FY2025: 57.52%Operating margin, FY2021: 9.89%Operating margin, FY2022: 5.94%Operating margin, FY2023: 7.83%Operating margin, FY2024: 7.98%Operating margin, FY2025: 7.66%Net margin, FY2021: 7.80%Net margin, FY2022: 4.48%Net margin, FY2023: 5.60%Net margin, FY2024: 5.02%Net margin, FY2025: 5.53%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 62.71%. Gross margin FY2022 60.99%. Gross margin FY2023 61.63%. Gross margin FY2024 59.40%. Gross margin FY2025 57.52%. Operating margin FY2021 9.89%. Operating margin FY2022 5.94%. Operating margin FY2023 7.83%. Operating margin FY2024 7.98%. Operating margin FY2025 7.66%. Net margin FY2021 7.80%. Net margin FY2022 4.48%. Net margin FY2023 5.60%. Net margin FY2024 5.02%. Net margin FY2025 5.53%.

Income trends

Revenue

270.28M USD+20.52%

Operating income

20.71M USD+15.70%

Net income

14.93M USD+32.57%
Income trends across reported periods296.69M USD191.06M USD85.44M USD−20.18M USDRevenue, FY2021: 117.06M USDRevenue, FY2022: 138.83M USDRevenue, FY2023: 183.01M USDRevenue, FY2024: 224.26M USDRevenue, FY2025: 270.28M USDOperating income, FY2021: 11.58M USDOperating income, FY2022: 8.25M USDOperating income, FY2023: 14.33M USDOperating income, FY2024: 17.9M USDOperating income, FY2025: 20.71M USDNet income, FY2021: 9.13M USDNet income, FY2022: 6.22M USDNet income, FY2023: 10.24M USDNet income, FY2024: 11.27M USDNet income, FY2025: 14.93M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 117.06M USD. Revenue FY2022 138.83M USD. Revenue FY2023 183.01M USD. Revenue FY2024 224.26M USD. Revenue FY2025 270.28M USD. Operating income FY2021 11.58M USD. Operating income FY2022 8.25M USD. Operating income FY2023 14.33M USD. Operating income FY2024 17.9M USD. Operating income FY2025 20.71M USD. Net income FY2021 9.13M USD. Net income FY2022 6.22M USD. Net income FY2023 10.24M USD. Net income FY2024 11.27M USD. Net income FY2025 14.93M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue270.28M USD224.26M USD183.01M USD138.83M USD117.06M USD
Cost of goods sold114.82M USD91.05M USD70.23M USD54.15M USD43.65M USD
Gross profit155.46M USD133.2M USD112.78M USD84.68M USD73.41M USD
Research and development3.02M USD3.07M USD2.78M USD2.7M USD2.11M USD
Selling, general, and administrative130.5M USD112.48M USD93.73M USD73.36M USD60.04M USD
Operating expenses134.75M USD115.3M USD98.45M USD76.43M USD61.83M USD
Interest expense1.18M USD776K USD424K USD197K USD318K USD
Depreciation and amortization28.61M USD25.37M USD21.86M USD15.63M USD11.31M USD
Operating income20.71M USD17.9M USD14.33M USD8.25M USD11.58M USD
Net income14.93M USD11.27M USD10.24M USD6.22M USD9.13M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
18%
2 beats, 7 misses, 2 met estimates
Average EPS surprise
-13.09%
11 comparable reports
Latest EPS result
0.07
Estimate 0.12 · Miss by 41.67%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.180.140.090.05Q1 '25MissQ2 '25MetQ3 '25MissQ4 '25MetQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 10, 2025: actual 0.1, estimate 0.11, surprise -9.09%, Miss. Q2 2025, reported May 7, 2025: actual 0.06, estimate 0.06, surprise 0.00%, Met estimate. Q3 2025, reported Aug 6, 2025: actual 0.08, estimate 0.085, surprise -5.88%, Miss. Q4 2025, reported Nov 5, 2025: actual 0.09, estimate 0.09, surprise 0.00%, Met estimate. Q1 2026, reported Mar 4, 2026: actual 0.14, estimate 0.12, surprise +16.67%, Beat. Q2 2026, reported May 5, 2026: actual 0.06, estimate 0.09, surprise -33.33%, Miss. Q3 2026, reported Aug 3, 2026: actual 0.07, estimate 0.12, surprise -41.67%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 0.13, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates84.34M74.86M65.37M55.89MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 10, 2025: actual 60.7M USD, estimate 59.4M USD, surprise +2.18%, Beat. Q2 2025, reported May 7, 2025: actual 59.13M USD, estimate 60.6M USD, surprise -2.43%, Miss. Q3 2025, reported Aug 6, 2025: actual 63.06M USD, estimate 63.5M USD, surprise -0.70%, Miss. Q4 2025, reported Nov 5, 2025: actual 71.91M USD, estimate 77.7M USD, surprise -7.45%, Miss. Q1 2026, reported Mar 4, 2026: actual 76.18M USD, estimate 77.7M USD, surprise -1.95%, Miss. Q2 2026, reported May 5, 2026: actual 75.41M USD, estimate 74.4M USD, surprise +1.36%, Beat. Q3 2026, reported Aug 3, 2026: actual 78.1M USD, estimate 78M USD, surprise +0.13%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 81.1M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

1 institution
Freedom BrokerdowngradeBuyHold

VMD news

VMD peers

ETFs holding VMD

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research VMD

research.disclaimer